Mark Thomas Taylor serves as Executive at Obagi Medical Products, Inc., where they oversee executive responsibilities. Since joining the company, Mark Thomas Taylor has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 25, 2013 involved selling 12,294 shares valued at $295.1K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Apr 25, 2013 | OMPI | $295.1K | Disposition | 12,294 | $24.00 | Discretionary |
Mark Thomas Taylor currently holds 0 shares of Obagi Medical Products, Inc. (OMPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Thomas Taylor has been a net neutral trader of OMPI stock. They have purchased $0 and sold $0 worth of shares.
Mark Thomas Taylor's most recent insider trade was on Apr 25, 2013, when they sold 12,294 shares at $24.00 per share.
Get notified when new Form 4 filings are submitted